AzTrials
AzTrials

DepressionHLGDepNCT03414606

Social Behavior in Depression

An observational study of Depression, run by Beijing Normal University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In the project, investigators basically plan to test the difference in social behavior and social cognition between depressive patients and healthy individuals. To test this, investigators plan to use traditional or novel behavioral experiment paradigms to target various behaviors. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Depression
How many people
25 participants
Where
1 siteChina
Study dates
1 Feb 2017to 1 Mar 2018
How long will I take part?
1 Month
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Individuals diagnosed with depression and healthy control

Who may be able to join

  • Age range between 18 and 60
  • Education experience above high school
  • Score for Hamilton's Depression Scale >=17
  • Diagnosis of depression through Scid

Who cannot join

  • Undergoing electric shock treatment in 3 months
  • Excluding those who with bipolar disorder
  • Excluding those who with postpartum depression
  • Excluding those who with hysteria

Trial locations and contacts

1 site in 1 country.

Yina Ma, Doctor contact

+8613810258647

yma@bnu.edu.cn

China1 site, 1 recruiting
  • Huilongguan Hospital

    Beijing

    Yina Ma, Doctor

    Yina Ma, Doctor

    Recruiting

Other trials in China

About this study

In the project, investigators basically plan to test the difference in social behavior and social cognition between depressive patients and healthy individuals. To test this, investigators plan to use traditional or novel behavioral experiment paradigms to target various behaviors.

Conditions
Depression
Medical subject headings
Depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prosocial behavior

    The prosocial behavior will be assessed by conventional economic games, including dictator game, message game, and ultimatum game.

    Measured: Baseline

  2. Cognitive flexibility

    Cognitive flexibility will be assessed by psychological cognitive paradigm, i.e. reversal learning paradigm. The participants will be asked to choose the item with high probability to win reward.

    Measured: Baseline

  3. Valuation of social information

    The valuation of social information was measured by psychological paradigm, developed from animal studies, called "pay-per-view". The participants will be asked make decision about more social information or more monetary reward.

    Measured: Baseline

  4. Optimism bias

    Participants will complete two sessions of life event estimation, i.e. estimating their likelihood of experiencing each event on a self-paced basis.

    Measured: Baseline

  5. Emotion recognition

    After viewing a video, participants will be asked to judge the person's attitude in the video. Through this paradigm, investigators could test emotional bias in social interaction in depressive patients.

    Measured: Baseline

  6. Model-free & model-based tendency

    Participants will be asked to complete a two-stage task, by choosing the stimuli with high probability to obtain reward.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2018
  2. Study start1 Feb 2017
  3. Primary completion16 Feb 2018 (estimated)
  4. Study completion1 Mar 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
25 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT03414606
Sponsor's protocol ID
HLGdepression
Acronym
HLGDep
Status last verified
Feb 2018
First submitted
22 Jan 2018
Last updated
6 Feb 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Depression, run by Beijing Normal University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yina Ma, Doctor (+8613810258647, yma@bnu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prosocial behavior (time frame: Baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in